Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Escalates Engagement With LASIK Providers In Letters To Medical Societies

This article was originally published in The Gray Sheet

Executive Summary

In addition to building pressure on the LASIK device field, recent letters to eye surgery and ophthalmology societies raise questions about FDA’s authority over physician activities.

You may also be interested in...



Regulatory News In Brief

FDA begins releasing summary review memos for 180-day PMA supplements as part of a transparency pilot. Invacare and FDA agree on consent decree terms. More regulatory news.

FDA Warns Clinics For Unlawful Advertising Of Allergan’s Lap-Band

Billboards and advertising inserts promoted the Lap-Band procedure without providing adequate risk information, FDA charges.

FDA Goes After Physicians For Off-label Device Promotion

FDA is on the lookout for physicians who promote medical devices for unapproved uses, as well as the companies that contract with them, regulators said last week at a Food and Drug Law Institute meeting

Related Content

Topics

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel